Included in the formulation
Chaga
raw materials.
inwards
Chaga
raw materials.
inwards
Chaga
raw materials.
inwards
Chaga
raw materials.
inwards
Pharmacodynamics:A plant-based product, contains pigments and polysaccharides, agaricin and humic-like chaglic acid, as well as trace elements: manganese, copper, cobalt.
Stimulates leukopoiesis, the immune system. Has a tonic effect on the central nervous system. Normalizes the function of the gastrointestinal tract.
Under the influence of agaric acid decreases sweating.
Due to the anesthetic effect it improves the quality of life of cancer patients.
Pharmacokinetics:Not described.
Indications:It is used for the treatment of functional disorders of the gastrointestinal tract, peptic ulcer of the stomach and duodenum, as well as for asthenic conditions, prolonged immunosuppressive therapy and in the postoperative period. Used as a symptomatic agent for cancer.
II.C76-C80.C80 Malignant neoplasm without specification of localization
XI.K20-K31.K22.4 Dyskinesia of the esophagus
XI.K20-K31.K25 Stomach ulcer
XI.K20-K31.K29.5 Chronic gastritis, unspecified
XI.K20-K31.K26 Duodenal ulcer
XI.K20-K31.K29 Gastritis and duodenitis
XXI.Z40-Z54.Z54 Condition of recovery
XXI.Z70-Z76.Z73.0 Overwork
Contraindications:Individual intolerance.
Carefully:Pregnancy and lactation, infantile age.
Pregnancy and lactation:Recommendations for FDA - Category B. It is used with caution in pregnancy and lactation.
Dosing and Administration:Inside, in the form of infusion, 1 tablespoon 3 times a day.
Side effects:Allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:Clinically significant interactions are not described.
Special instructions:During treatment it is recommended to adhere to the milk-vegetable diet with the exception of the diet of meat and fats.